--(BUSINESS WIRE)--Cencora, Inc. (NYSE ... value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals ...
February 07, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE ... to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals ...
Buying $100 In COR: If an investor had bought $100 of COR stock 5 years ago, it would be worth $257.27 today based on a price ...
Our leadership supporting specialty providers is a key differentiator and growth driver for Cencora and we've evolved our service offerings over time. Over decades, we've deepened our ...
Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...
Through the sure supply program, providers can help lessen the impacts of shortages for at-risk treatments so they can focus on what matters most—taking care of their patients.” Cencora ...
Our leadership supporting specialty providers is a key differentiator and growth driver for Cencora, and we have evolved our service offerings over time. Over decades, we’ve deepened our ...
Feb 5 (Reuters) - Drug distributor Cencora (COR.N), opens new tab raised ... is the world’s largest multimedia news provider, reaching billions of people worldwide every day.
Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results